Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

This company develops and commercializes innovative products to help stimulate the body's natural tissue regenerative process. This stock closed up 5.1% to $4.05 in recent trading.

Today's Range: $3.86-$4.18

52-Week Range: $1.87-$4.83

Volume: 51,000

Three-Month Average Volume: 73,624

From a technical perspective, BMTI trended up today right off some near-term support at $3.80 with light volume. This move is quickly pushing BMTI within range of triggering a near-term breakout trade. That trade will hit once BMTI manages to clear its 50-day at $4.13 and then some more overhead resistance at $4.19 with high volume.

Traders should now look for long-biased trades in BMTI as long as it's trending above today's low of $3.86, and then once it sustains a move or close above those breakout levels with volume that hits near or above 73,624 shares. If that breakout triggers soon, then look for BMTI to re-test or possibly take out its next major overhead resistance levels at $4.53 to $4.83. Any high-volume move above those levels will then put $5 to $6 into focus for BMTI.

This is an in-vitro diagnostic company, engaged in commercializing a proprietary tear testing platform that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film. This stock closed up 8.5% to $4.45 in recent trading.

Today's Range: $4.06-$4.55

52-Week Range: $0.98-$4.88

Volume: 663,000

Three-Month Average Volume: 134,276

Shares of TEAR ripped to the upside today after the company reported third quarter net revenues of $1.2 million, an increase of 264% from $333,000 for the same period in 2011 and up 69% sequentially from $716,000 in the previous quarter.

From a technical perspective, TEAR bounced strongly right off its 50-day moving average of $4.02 with monster upside volume. This move is quickly pushing TEAR within range of triggering a major breakout trade. That trade will hit once TEAR manages to take out some key overhead resistance levels at $4.60 to $4.88 with high volume.

Traders should now look for long-biased trades in TEAR as long as it's trending above its 50-day at $4.02, and then once it sustains a move or close above those breakout levels with volume that hits near or above 134,276 shares. If that breakout triggers soon, then TEAR will set up to trend north of $5 in the near future. Some possible upside targets in the short-term are $5.50 to $6.50.

This company is engaged in the secondary market for life insurance known as life settlements. This stock closed up 8.37% to $2.59 in recent trading.

Today's Range: $2.34-$2.63

52-Week Range: $1.08-$7.49

Volume: 90,000

Three-Month Average Volume: 534,419

From a technical perspective, LPHI soared higher today right around some near-term support at $2.25 with light volume. This move is quickly pushing LPHI within range of triggering a major breakout trade. That trade will hit once LPHI takes out its 50-day at $2.16 and then once it clears some more near-term overhead resistance levels at $2.69 to $2.78 with high volume.

Traders should now look for long-biased trades in LPHI as long as it's trending above its 50-day at $2.16, and then once it sustains a move or close above those breakout levels with volume that hits near or above 534,419 shares. If that breakout triggers soon, then LPHI will set up to re-test or possibly take out its nest major overhead resistance levels at $4.12 to $4.50.

This company is engaged in research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. This stock closed up 7.7% to $2.78 in recent trading.

Today's Range: $2.56-$2.81

52-Week Range: $1.33-$3.12

Volume: 291,000

Three-Month Average Volume: 164,030

Shares of ENZ soared higher today after the company said its Enzo Clinical Labs has introduced a new diagnostic test that assist in risk assessment and early detection of lung cancer. It is being made available to physicians in the New York metropolitan market as well as New Jersey and Eastern Pennsylvania, where Enzo is the only clinical laboratory making the test available within those areas.

From a technical perspective, ENZ bounced higher today right around some near-term support at $2.47 with above-average volume. This stock has been trending sideways for the last month, with shares moving between $2.40 on the downside and $3.09 on the upside. Shares of ENZ are now pushing within range of triggering a major breakout trade. That trade will hit once ENZ manages to take out some near-term overhead resistance levels at $2.80 to $3.09 and then once it clears some past overhead resistance at $3.12 with high volume.

Traders should now look for long-biased trades in ENZ as long as it's trending above $2.47, and then once it sustains a move or close above those breakout levels with volume that hits near or above 164,030 shares. If that breakout triggers soon, then ENZ will set up to re-test or possibly take out its next major overhead resistance levels at $4 to $4.88. Keep in mind that any move above $3.12 would send ENZ into new 52-week high territory, which is bullish technical price action.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.